Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
Thomas Jefferson University
Thomas Jefferson University
Center for International Blood and Marrow Transplant Research
Massachusetts General Hospital
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
University Hospital, Toulouse
Medical College of Wisconsin
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Massachusetts General Hospital
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
University of Rochester
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center